Patterns of diuretic titration during inpatient management of acute decompensated heart failure

被引:0
作者
Bullock, Griffin [1 ]
Jacobs, Joshua A. [2 ,3 ]
Carey, Jessica R. [3 ]
Pan, Irene Z. [3 ]
Kinsey, M. Shea [3 ]
Sideris, Konstantinos [4 ]
Kapelios, Chris J. [4 ]
Stehlik, Josef [4 ]
Fang, James C. [4 ]
Das, Sandeep [5 ]
Carter, Spencer J. [4 ]
机构
[1] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Clin Informat, 6500 Wilshire Blvd,Suite 200, Los Angeles, CA 90048 USA
[2] Univ Utah, Spencer Fox Eccles Sch Med, Intermt Healthcare Dept Populat Hlth Sci, Salt Lake City, UT USA
[3] Univ Utah, Univ Utah Hlth, Dept Pharm, Salt Lake City, UT USA
[4] Univ Utah, Spencer Fox Eccles Sch Med, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT USA
[5] Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Cardiovasc Med, Dallas, TX USA
关键词
REDUCED EJECTION FRACTION; EFFICACY; HOSPITALIZATION; CONGESTION; SAFETY;
D O I
10.1016/j.ahj.2024.12.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Hospitalization rates for acute decompensated heart failure (ADHF) have increased, resulting in 6.5 million hospital days annually. Despite this, optimal diuretic strategies for managing ADHF remain unclear, highlighting the need to analyze diuretic practice patterns in ADHF treatment. Methods We performed a retrospective cohort analysis of adults hospitalized for ADHF, regardless of left ventricular ejection fraction (LVEF) between January 1, 2014 and December 21, 2021 at a large, quaternary healthcare system to determine diuretic practice patterns. We performed multivariable regression analyses to assess time to initial, second, and maximum diuretic therapy with hospital length of stay (LOS) and 30-day readmission. Results Among 4,298 adults admitted for ADHF (mean age 63 years, 62 % male, 52 % LVEF <= 40 %) median time to max diuretic therapy was 1.8 (0.7, 3.8) days. Median time to initial IV loop diuretic dose was 3.6 (2.1, 6.5) hours, while time to second dose of IV loop diuretic dose was 10.2 (6.3, 15.1) hours. Time to initial IV loop diuretic, time to second IV loop diuretic dose, and time to maximum diuretic therapy were all positively associated with increased LOS but were not associated with 30-day readmission. There was wide variation in loop diuretic escalation strategies and use of sequential nephron blockade. Conclusion There was wide variation in diuretic strategies at a single academic medical center. Increased time to initial IV loop diuretic, time between diuretic doses, and longer time to max diuretic therapy were associated with increased LOS but were not associated with 30-day readmission suggesting different diuretic strategies may affect patient outcomes and
引用
收藏
页码:30 / 39
页数:10
相关论文
共 22 条
  • [1] Diuresis Efficacy in Ambulatory Congested Heart Failure Patients Intrapatient Comparison of 3 Diuretic Regimens (DEA-HF)
    Abbo, Aharon
    Gruber, Amit
    Volis, Ina
    Aronson, Doron
    Girerd, Nicolas
    Kristensen, Soren Lund
    Zukermann, Robert
    Alberkant, Natalia
    Sitnitsky, Elena
    Kruger, Anton
    Khasis, Polina
    Bravo, Evgeny
    Elad, Boaz
    Levin, Ludmila Helmer
    Caspi, Oren
    [J]. JACC-HEART FAILURE, 2024, 12 (08) : 1396 - 1405
  • [2] Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
    Ambrosy, Andrew P.
    Pang, Peter S.
    Khan, Sadiya
    Konstam, Marvin A.
    Fonarow, Gregg C.
    Traver, Brian
    Maggioni, Aldo P.
    Cook, Thomas
    Swedberg, Karl
    Burnett, John C., Jr.
    Grinfeld, Liliana
    Udelson, James E.
    Zannad, Faiez
    Gheorghiade, Mihai
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (11) : 835 - 843
  • [3] [Anonymous], 2022, AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | circulation, DOI [10.1161/CIR.0000000000001063, DOI 10.1161/CIR.0000000000001063]
  • [4] HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
    Bozkurt, Biykem
    Writing Comm, Tariq
    Ahmad, Tariq
    Alexander, Kevin
    Baker, William L.
    Bosak, Kelly
    Breathett, Khadijah
    Carter, Spencer
    Drazner, Mark H.
    Dunlay, Shannon M.
    Fonarow, Gregg C.
    Greene, Stephen J.
    Heidenreich, Paul
    Ho, Jennifer E.
    Hsich, Eileen
    Ibrahim, Nasrien E.
    Jones, Lenette M.
    Khan, Sadiya S.
    Khazanie, Prateeti
    Koelling, Todd
    Lee, Christopher S.
    Morris, Alanna A.
    Page II, Robert L.
    Pandey, Ambarish
    Piano, Mariann R.
    Sandhu, Alexander T.
    Stehlik, Josef
    Stevenson, Lynne W.
    Teerlink, John
    Vest, Amanda R.
    Yancy, Clyde
    Ziaeian, Boback
    [J]. JOURNAL OF CARDIAC FAILURE, 2025, 31 (01) : 66 - 116
  • [5] Efficacy and Safety of Spironolactone in Acute Heart Failure The ATHENA-HF Randomized Clinical Trial
    Butler, Javed
    Anstrom, Kevin J.
    Felker, G. Michael
    Givertz, Michael M.
    Kalogeropoulos, Andreas P.
    Konstam, Marvin A.
    Mann, Douglas L.
    Margulies, Kenneth B.
    McNulty, Steven E.
    Mentz, Robert J.
    Redfield, Margaret M.
    Tang, W. H. Wilson
    Whellan, David J.
    Shah, Monica
    Desvigne-Nickens, Patrice
    Hernandez, Adrian F.
    Braunwald, Eugene
    [J]. JAMA CARDIOLOGY, 2017, 2 (09) : 950 - 958
  • [6] Trends in Heart Failure Hospitalizations in the US from 2008 to 2018
    Clark, Katherine A. A.
    Reinhardt, Samuel W.
    Chouairi, Fouad
    Miller, P. Elliott
    Kay, Bradley
    Fuery, Michael
    Guha, Avirup
    Ahmad, Tariq
    Desai, Nihar R.
    [J]. JOURNAL OF CARDIAC FAILURE, 2022, 28 (02) : 171 - 180
  • [7] Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study
    Dauw, Jeroen
    Charaya, Kristina
    Lelonek, Malgorzata
    Zegri-Reiriz, Isabel
    Nasr, Samer
    Paredes-Paucar, Cynthia P.
    Borbely, Attila
    Erdal, Fatih
    Benkouar, Riad
    Cobo-Marcos, Marta
    Barge-Caballero, Gonzalo
    George, Varghese
    Zara, Cornelia
    Ross, Noel T.
    Barker, Diane
    Lekhakul, Annop
    Frea, Simone
    Ghazi, Azmee M.
    Knappe, Dorit
    Doghmi, Nawal
    Klincheva, Milka
    Fialho, Ines
    Bovolo, Virginia
    Findeisen, Hajo
    Alhaddad, Imad A.
    Galluzzo, Alessandro
    de la Espriella, Rafael
    Tabbalat, Ramzi
    Miro, Oscar
    Singh, Jagdeep S.
    Nijst, Petra
    Dupont, Matthias
    Martens, Pieter
    Mullens, Wilfried
    [J]. CIRCULATION-HEART FAILURE, 2024, 17 (01) : E011105
  • [8] Diuretic Strategies in Patients with Acute Decompensated Heart Failure
    Felker, G. Michael
    Lee, Kerry L.
    Bull, David A.
    Redfield, Margaret M.
    Stevenson, Lynne W.
    Goldsmith, Steven R.
    LeWinter, Martin M.
    Deswal, Anita
    Rouleau, Jean L.
    Ofili, Elizabeth O.
    Anstrom, Kevin J.
    Hernandez, Adrian F.
    McNulty, Steven E.
    Velazquez, Eric J.
    Kfoury, Abdallah G.
    Chen, Horng H.
    Givertz, Michael M.
    Semigran, Marc J.
    Bart, Bradley A.
    Mascette, Alice M.
    Braunwald, Eugene
    O'Connor, Christopher M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) : 797 - 805
  • [9] Reasons for Guideline Nonadherence at Heart Failure Discharge
    Gilstrap, Lauren G.
    Stevenson, Lynne W.
    Small, Roy
    Parambi, Ron
    Hamershock, Rose
    Greenberg, Jeffrey
    Carr, Christina
    Ghazinouri, Roya
    Rathman, Lisa
    Han, Elizabeth
    Mehra, Mandeep R.
    Desai, Akshay S.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (15):
  • [10] In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States
    Greene, Stephen J.
    Triana, Taylor S.
    Ionescu-Ittu, Raluca
    Burne, Rebecca M.
    Guerin, Annie
    Borentain, Maria
    Kessler, Paul D.
    Tugcu, Aylin
    DeSouza, Mary M.
    Felker, G. Michael
    Chen, Lei
    [J]. JACC-HEART FAILURE, 2020, 8 (11) : 943 - 953